BioSpace News Archive

Pharm Country

Soligenix Announces Closing of $8.5 Million Public Offering

Soligenix, Inc. announced the closing of its previously announced public offering of 6,538,500 shares of common stock and common warrants to purchase up to 6,538,500 shares of common stock at a combined public offering price of $1.30.

May 9, 2023
·
6 min read
Genetown

Ironwood Pharmaceuticals to Participate in The JMP Securities Life Sciences Conference

Ironwood Pharmaceuticals, Inc. announced that management will participate in a fireside chat at The JMP Securities Life Sciences Conference on Tuesday, May 16, 2023 at 1:30 p.m. ET at the New York Hilton Midtown.

May 9, 2023
·
1 min read
Business

Amyris, Inc. Reports First Quarter 2023 Financial Results

Amyris, Inc. announced financial results for the first quarter ended March 31, 2023.

May 9, 2023
·
16 min read
Pharm Country

Halberd Pre-Clinical Test Protocol Approved

Halberd Corporation (OTC PINK:HALB ) researchers at Mississippi State University College of Veterinary Medicine have received approval of its test protocol, and test subjects have been ordered.

May 9, 2023
·
3 min read
Lone Star Bio

HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG

Heart Test Laboratories, Inc. today announces completion of patient enrollment for its MyoVista wav ECG pivotal study for FDA De Novo submission.

May 9, 2023
·
4 min read
Nascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual Meeting

Nascent Biotech, Inc. announced today that the Company has been selected for a poster presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting held in Chicago on June 2-6, 2023.

May 9, 2023
·
3 min read
Business

Baxter Announces CFO Transition

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the departure of executive vice president and chief financial officer (CFO) Jay Saccaro.

May 9, 2023
·
3 min read
Business

Agenus Provides Corporate Update and First Quarter 2023 Financial Results

Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company with an extensive pipeline of clinical and preclinical-stage cancer treatments, today provided a corporate update and reported financial results for the first quarter 2023.

May 9, 2023
·
11 min read
BioForest

Affini-T Therapeutics to Present Novel CRISPR Gene Editing Data from its Oncogenic Driver Program Targeting KRAS at the American Society of Gene and Cell Therapy 26th Annual Meeting

Affini-T Therapeutics, Inc. today announced that preclinical data for its oncogenic driver program targeting KRAS G12D, AFNT–212, will be presented at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting in Los Angeles, California.

May 9, 2023
·
2 min read
Biotech Bay

SonALAsense Welcomes Dr. Ely Benaim as Chief Medical Officer and Executive Vice President of Development

SonALAsense, a pioneer in the development of non-invasive Sonodynamic Therapy using SONALA-001 in combination with Insightec’s MR-guided focused ultrasound, has appointed Ely Benaim, M.D., as Chief Medical Officer and Executive Vice President of Development.

May 9, 2023
·
3 min read